Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2020 Apr 18;76(2):184–193. doi: 10.1053/j.ajkd.2019.12.010

Table 3.

Crude rate of events (per 100 person-years) following annual visits classified by reported Opioid and NSAID use*

Pre-kidney failure Death Kidney Failure with KRT Composite kidney disease outcome Pre-kidney failure Hospitalization
Analgesic use events total visits Rate per 100 visits (95 % CI) events total visits Rate per 100 visits (95 % CI) events total visits Rate per 100 visits (95 % CI) events total visits Rate per 100 visits (95 % CI)
Opioid (no NSAID) 85 2420 3.5 (2.8, 4.3) 84 1998 4.2 (3.4, 5.2) 114 1942 5.9 (5.3, 6.3) 2169 1998 108.6 (99.1, 118.9)
NSAID (no opioid) 38 2780 1.4 (1.0, 1.9) 46 2465 1.9 (1.4, 2.5) 60 2454 2.4 (1.9, 3.2) 1429 2465 58.0 (51.5, 65.3)
Other (non-opioid, non-NSAID) 402 19097 2.1 (1.9, 2.3) 683 15960 4.3 (4.0, 4.6) 930 15744 5.9 (5.5, 6.3) 9786 15960 61.3 (58.6, 64.2)
Opioid & NSAID 19 541 3.5 (2.2, 5.5) 12 476 2.5 (1.4, 4.4) 11 473 2.3 (1.2, 4.2) 426 476 89.5 (75.2, 106.6)
*

Total number of visits used for pre-kidney failure death is 24838. Total number of visits for kidney failure with KRT, and pre-kidney failure hospitalization is 20899. Total number of visits for the composite kidney disease outcome is 20613.